trending Market Intelligence /marketintelligence/en/news-insights/trending/owrgybkjkrz-8uqhnb3kpw2 content esgSubNav
In This List

BARD1 Life Sciences plans to raise A$1.3M via placement of shares

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


BARD1 Life Sciences plans to raise A$1.3M via placement of shares

BARD1 Life Sciences Ltd. agreed to sell 86,666,666 shares at 1.5 Australian cents each to a group of investors.

The company expects to raise A$1.3 million through the placement, which will go toward its ongoing research and development programs, as well as commercial initiatives and general working capital purposes.

The placement is expected to settle by March 26.

Australia-based BARD1 Life Sciences develops therapies and diagnostic tests for cancer.